BELGIUM; FRANCE —65 Equity Partners has acquired a minority stake in Swedish hypercar manufacturer Koenigsegg Automotive, propelling the investment firm past US$2 billion in cumulative capital deployed globally since its establishment five years ago. The transaction marks the fourth European investment completed by the firm within a 24-month period and provides fresh capital to accelerate Koenigsegg Automotive's engineering roadmap, operational scaling, and readiness for a potential public market listing. Founder Christian von Koenigsegg retains majority ownership and continues to lead executive operations.
Established in 1994, Koenigsegg Automotive designs and manufactures high-performance luxury hypercars, maintaining an order backlog extending beyond three years and recording average annual revenue growth of 80 percent since 2022. 65 Equity Partners operates as a global investment platform specializing in flexible, non-controlling equity solutions for established, founder-led, and family-owned enterprises across 19 global portfolio companies.
The transaction highlights an accelerating structural shift in European private equity toward minority growth financing. Empirical findings from a joint study by 65 Equity Partners and INSEAD, examining over 19,000 enterprises across nine jurisdictions, indicate that 26 percent of family-owned businesses plan to raise external institutional capital within three to five years, whereas only 3 percent anticipate pursuing an outright sale. European founders increasingly prioritize capital structures that finance global expansion and research without diluting operational autonomy or altering corporate culture.
Across European industrial and service sectors, minority institutional partnerships are reshaping capital allocation strategies. Prior to backing Koenigsegg Automotive, 65 Equity Partners deployed capital into French real estate project management consultancy Theop to support digital transformation, artificial intelligence integration, and cross-border expansion across France, Spain, Belgium, and Italy. In 2025, the firm also invested in United Kingdom-based safety systems provider Kee Safety and partnered with the Braglia family in Switzerland to provide inaugural institutional funding for the merger of pharmaceutical groups HAS and Cerbios.
For institutional investors and corporate decision-makers, the expansion of non-controlling growth equity presents an alternative route to accessing high-performing mid-market and luxury manufacturing assets that remain closed to traditional buyouts. Businesses utilizing minority capital gain institutional governance and pre-IPO structuring capabilities while preserving founder-led strategic continuity.